CLSA Events, Event Fellows, Home Events

Entrepreneur and Investor Roundtables 2013

BayBio Entrepreneur & Investor Roundtables 2013

CHI's 20th Annual Molecular Med Tri-Conference
Join over 3,000 of your colleagues in interactive lectures, discussions, and various networking receptions to hear differing views and perspectives on poignant issues facing you and our industry today. Roundtable attendees receive complimentary access to the exhibit on Feb. 14.

The BayBio Entrepreneur and Investor Roundtables is a unique event designed to act as a catalyst for burgeoning entrepreneurs, and is well known for its iconic ‘speed-dating’ format. The Roundtables facilitate introductions, dialogue and connections between life science entrepreneurs and investors. This event provides early-stage companies with accessibility into the capital markets while providing investors a first look at intriguing innovations. Annually, VC firms and Angel Investors listen to focused pitches from dozens of biotech entrepreneurs, thereby opening the door for future growth. This event has grown each year and now attracts over 200 people annually, with the expectation of even a greater number of registrants in 2013.

2013 Confirmed Participating Investors To Date

Band of Angels
Baxter Ventures
Beijing E-town Technology Venture Capital Investment Management Company
Breakout Labs/Thiel Foundation
California Institute for Regenerative Medicine
Claremont Creek Ventures
CMEA Capital
Hamamatsu Photonics
Harvard Angels
Johnson & Johnson Development Corporation
Johnson & Johnson Innovation Centers
Life Science Angels, Inc.
MPM Capital
Paradigm Bioventures
Pfizer Inc.
QB3 & Mission Bay Capital
Rusnano USA, Inc.
Sacramento Angels
Sand Hill Angels
Shoreline Ventures
Staidson (US) Pharmaceuticals
Takeda Ventures, Inc.
Texas Pacific Group
The Angels Forum
Vantage Point Venture Partners
Velocity Pharmaceutical Development
Vivo Ventures

2013 Confirmed Participating Entrepreneurs To Date

21 SP, Inc.
3S Corporation
7Summits Health, Inc.
Alquest Therapeutics, Inc.
Alzeca Biosciences
Applied Immunology, Inc.
Aronora, Inc.
Artery Therapeutics, Inc.
Asta Fluidic Technologies, Inc.
Bell Biosystems
Bioxiness Pharmaceuticals
CardioCanary Inc
Clear Therapeutics, Inc.
Coyote Pharmaceuticals, Inc.
Cyterion, Inc.
CytoTrack ApS
Daya Drug Discoveries, Inc.
DELOS Pharmaceuticals, Inc
Denovo Biomarkers
DermDx Inc.
Dolorna, Inc.
Endocrine Technologies, Inc.
Epigen Biosciences Inc.
Everest Biosciences, Inc.
First Warning Systems, Inc.
G2B Pharma Inc.
GigaGen Inc.
G-Tech Medical
HETERO Therapeutics
Innovation Pathways
Innovation Ulster Limited
Integrated Fluidics Inc.
IR2DX, Inc.
KineMed, Inc.
Life Line Sciences
Live Cell Assays, LLC
LiveLeaf, BioScience
MandalMed, Inc.
Maya Clinicals Inc
Nizyme, Inc.
NuMedii, Inc.
Nuvik Therapeutics, Inc.
Olema Pharmaceuticals, Inc.
Oncology Venture
Paloza (Molecule)
PCUT BioPartners, Inc.
PLC Diagnostics
ProLynx LLC
Protagonist Therapeutics Inc.
Sandstone Diagnostics, Inc.
Shrewd Consulting LLC/LifeSplice Pharma
Single Cell Technology
SiteOne Therapeutics
Solidus Biosciences, Inc.
SomaGenics, Inc.
Spiral Devices, LLC
Symic Biomedical
Synergys Biotherapeutics, Inc.
Tansia Health Inc.
TF Instruments
Universal Bio Mining
Valley Fever Solutions
Vanton Research Laboratory, LLC
Visionary Pharmaceuticals
Wasatch Microfluidics
WHO Inc.
Xalud Therapeutics, Inc.
Xcell Biosciences Inc.
Xpand Biotechnology b.v.
What: BayBio Entrepreneur & Investor Roundtables
When: February 14, 2013
4:00PM – 7:00PM
Where: Gateway Ballroom 104
The Moscone Center North
747 Howard St.
San Francisco, CA 94103
Parking: $3.50/hour
Fifth and Mission Garage
Attire: Business attire suggested
Cost: Investors: Complimentary
Entrepreneurs: $40.00
No onsite registration is available

* Only company profiles submitted to BayBio on or before January 28, 2013 will be included in printed materials and on event Web site

Please mail your event-related questions to: or you can contact us via phone: 650-871-3257.